Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment

ConclusionsThe differential diagnosis of hepatitis in MS patients should include AIH and in particular when immunomodulatory treatment has been preceded. Autoantibody testing and liver histology play fundamental role in establishing a prompt diagnosis of AIH in these patients. Treatment of AIH in patients with MS seems safe and efficient as complete or partial response was recorded in all of our patients.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research